Imaging may predict whether drag addicts can benefit from therapy

被引：0
|
作者：
Anon
机构：
来源：
Biophotonics International | 2001年 / 8卷 / 05期
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] FACTORS THAT PREDICT WHICH PRETERM INFANTS BENEFIT MOST FROM MASSAGE THERAPY
    SCAFIDI, FA
    FIELD, T
    SCHANBERG, SM
    JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS, 1993, 14 (03): : 176 - 180
  • [32] Patients with epilepsy can benefit from early Add-on-Therapy
    Hepfinger, Peter
    NERVENHEILKUNDE, 2010, 29 (05) : 324 - 325
  • [33] Nomogram to predict the benefit from salvage systemic therapy for advanced urothelial carcinoma
    Sonpavde, Guru
    Pond, Gregory R.
    Fougeray, Ronan
    Bellmunt, Joaquim
    BJU INTERNATIONAL, 2015, 115 (06) : 854 - 855
  • [34] Who May Benefit From Armeo Power Treatment? A Neurophysiological Approach to Predict Neurorehabilitation Outcomes
    Calabro, Rocco Salvatore
    Russo, Margherita
    Naro, Antonino
    Milardi, Demetrio
    Balletta, Tina
    Leo, Antonino
    Filoni, Serena
    Bramanti, Placido
    PM&R, 2016, 8 (10) : 971 - 978
  • [35] IABP as a Bridge to Transplantation: Can we Identify Who May Benefit From a LVAD?
    Guha, A.
    Ali, A.
    Nguyen, D.
    Bruckner, B.
    Trachtenberg, B.
    Graviss, E. A.
    Bhimaraj, A.
    Park, M. H.
    Hussain, I.
    Suarez, E. E.
    Torre-Amione, G.
    Estep, J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2018, 37 (04): : S267 - S267
  • [36] Panel of Serum Biomarkers May Predict Benefit from Bevacizumab (BEV) in Advanced NSCLC Patients
    Braun, E.
    Fidler, M.
    Basu, S.
    Gangaram, A.
    Walters, K. Kaiser
    Karmali, R.
    Fhied, C.
    Borgia, J. A.
    Bonomi, P. D.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (09) : S219 - S219
  • [37] PANEL OF SERUM BIOMARKERS MAY PREDICT BENEFIT FROM BEVACIZUMAB (BEV) IN ADVANCED NSCLC PATIENTS
    Braun, Eduardo
    Fidler, Mary Jo
    Basu, Sanjib
    Gargaram, Anjali
    Walters, Kelly
    Fhied, Cristina
    Borgia, Jeffrey A.
    Bonomi, Philip D.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (07) : S124 - S125
  • [38] Wwox expression may predict benefit from adjuvant tamoxifen in randomized breast cancer patients
    Eremo, Anna Gothlin
    Wegman, Pia
    Stal, Olle
    Nordenskjold, Bo
    Fornander, Tommy
    Wingren, Sten
    ONCOLOGY REPORTS, 2013, 29 (04) : 1467 - 1474
  • [39] CT-based radiomics nomogram may predict who can benefit from adaptive radiotherapy in patients with local advanced-NSCLC patients
    Zhou, Chao
    Hou, Liqiao
    Tang, Xingni
    Liu, Changxing
    Meng, Yinnan
    Jia, Haijian
    Yang, Haihua
    Zhou, Suna
    RADIOTHERAPY AND ONCOLOGY, 2023, 183
  • [40] Negative argininosuccinate synthetase expression in melanoma tumours may predict clinical benefit from arginine-depleting therapy with pegylated arginine deiminase
    Feun, L. G.
    Marini, A.
    Walker, G.
    Elgart, G.
    Moffat, F.
    Rodgers, S. E.
    Wu, C. J.
    You, M.
    Wangpaichitr, M.
    Kuo, M. T.
    Sisson, W.
    Jungbluth, A. A.
    Bomalaski, J.
    Savaraj, N.
    BRITISH JOURNAL OF CANCER, 2012, 106 (09) : 1481 - 1485
12345